Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease

Summary

The purpose of this study is to determine if either a targeted type of talk therapy (Phase I) or medication, Wellbutrin, (Phase II) improve sleep disturbance and/or fatigue in individuals with Inflammatory Bowel Disease (IBD).

Timeline

Start

2013-07

Primary completion

2016-06-30

Completion

2016-06-30

Drugs

Indications